Clavulanic acid (* Co-amoxiclav Es Camox, * Co-amoxiclav Es Austell, * Co-amoxiclav Es Apex, Co-amoxiclav Bd S Austell, Co-amoxiclav Bd Sf Austell, Camox-co-amoxiclav Bd S, Camox-co-amoxiclav Bd Sf, Co-amoxiclav Bd S Apex, Co-amoxiclav Bd Sf Apex, Austell-co-amoxiclav, Austell Co-amoxiclav)
Clavulanic acid
Austell Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Austell Pharmaceuticals (Pty) Ltd
- Registrations
- 11
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| * co-amoxiclav es 600 camox EACH 5,0 ml SUSPENSION CONTAINS: AMOXICILLIN TRIHYDRATE EQUIVALENT TO AMOXICILLIN 600,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 42,9 mg | 600 | 48112248/20.1.2/1122 | Registered | Not determined | None |
| * co-amoxiclav es 600 austell EACH 5,0 ml SUSPENSION CONTAINS :AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 600,0 mg, POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 42,9 mg | 600 | 48112348/20.1.2/1123 | Registered | Not determined | None |
| * co-amoxiclav es 600 apex EACH 5,0 ml SUSPENSION CONTAINS: AMOXICILLIN TRIHYDRATE EQUIVALENT TO AMOXICILLIN 600,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 42,9 mg | 600 | 48112448/20.1.2/1124 | Registered | Not determined | None |
| Co-amoxiclav bd s austell EACH 5,0 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 200,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 28,5 mg | Not listed | 48117548/20.1.2/1175 | Registered | Not determined | None |
| Co-amoxiclav bd sf austell EACH 5,0 ml SUSPENSION CONTAINS :AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 400,0 mg, POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 57,0 mg | Not listed | 48117648/20.1.2/1176 | Registered | Not determined | None |
| Camox-co-amoxiclav bd s EACH 5,0 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 200,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 28,5 mg | Not listed | 48117748/20.1.2/1177 | Registered | Not determined | None |
| Camox-co-amoxiclav bd sf EACH 5,0 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 400,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 57,0 mg | Not listed | 48117848/20.1.2/1178 | Registered | Not determined | None |
| Co-amoxiclav bd s apex EACH 5,0 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 200,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 28,5 mg | Not listed | 48117948/20.1.2/1179 | Registered | Not determined | None |
| Co-amoxiclav bd sf apex EACH 5,0 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 400,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 57,0 mg | Not listed | 48118048/20.1.2/1180 | Registered | Not determined | None |
| Austell-co-amoxiclav 375 MG EACH TABLET CONTAINS :AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250,0 mg, POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 125,0 mg | 375 mg | A390488A39/20.1.2/0488 | Registered | Not determined | None |
| Austell co-amoxiclav 625 MG EACH TABLET CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 500,0 mg POTASSIUM CLAVULANATE EQUIVALENT TO CLAVULANIC ACID 125,0 mg | 625 mg | A390489A39/20.1.2/0489 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Amoxicillin
Consolidated Schedules 06 July 2026, line 5238
S4: Clavulanic acid
Consolidated Schedules 06 July 2026, line 5829
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2R,3Z,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 5280980.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.